Japan approves AstraZeneca’s Calquence for adult patients with treatment-naïve CLL EP News Bureau Dec 29, 2022 Calquence was previously approved in Japan for the treatment of adults with relapsed or refractory Chronic Lymphocytic Leukaemia…
AztraZeneca to launch oncology drug Calquence in India EP News Bureau Oct 16, 2020 It is used to treat mantle cell lymphoma and chronic lymphocytic leukaemia
AstraZeneca blood cancer drug shows signs of helping COVID-19 patients Reuters Jun 8, 2020 Results from the preliminary research involving 19 patients, which was backed by the United States National Institutes of Health,…
AstraZeneca to test impact of cancer drug Calquence on coronavirus patients Reuters Apr 14, 2020 Calquence (acalabrutinib) belongs to a class of drugs called Bruton’s tyrosine kinase (BTK) inhibitors which can suppress…